Moderate riskFDA DrugClass II

IntegraDose Vasopressin syringes recalled for subpotent drug content

IntegraDose Compounding Services LLC is recalling Vasopressin 2 Units/2 mL syringes because the drug may contain less active ingredient than labeled. This affects two specific lots distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have syringes from lot 20260327VAS-3 (expires 05/26/2026) or lot 20260320VAS-3 (expires 05/19/2026).
  2. Contact your pharmacy or healthcare provider if you have received these syringes.
  3. Do not use the recalled syringes without consulting your provider.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
Sold in
Nationwide

Details

Units affected
287 units
Illnesses reported
None reported
Manufactured in
3650 Victoria St N Ste 900, Shoreview, MN, United States
Classification
Class II
Recall number
D-0593-2026

In the FDA's words

Description
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1. Subpotent Drug Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026. Distribution: U.S.A. Nationwide Affected quantity: 287 units
Hazard
Subpotent Drug

Related topics